Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination
about
Safety of engineered allergen-specific immunotherapy vaccinesVaccines for allergyIdentification of critical amino acids in an immunodominant IgE epitope of Pen c 13, a major allergen from Penicillium citrinumAir Pollution and Climate Change Effects on Allergies in the Anthropocene: Abundance, Interaction, and Modification of Allergens and Adjuvants.Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy.Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptidesThe influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.Recombinant allergen immunotherapy: clinical evidence of efficacy--a review.Recombinant allergens for pollen immunotherapy.Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients.Epicutaneous immunotherapy with a hypoallergenic Bet v 1 suppresses allergic asthma in a murine model.Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber.Hypoallergenic molecules for subcutaneous immunotherapy.Novel strategies in immunotherapy for allergic diseases.
P2860
Q26860962-53408F57-F371-4492-899F-D63055E40B07Q27006550-93B2B989-78B6-4674-B32E-75370E665100Q28482224-76E0350F-6FD7-4A95-B72C-D7D730C9510DQ33752095-208D55FF-E873-4A53-8330-2A8CEF32DC36Q34415246-57B47F15-FFBB-41B6-827E-F30D520600C6Q36125658-06B87FFC-8496-4C10-AF09-9714586FAD9DQ36125684-9E24F978-5DB6-47F9-A686-B5ED2764EB02Q36901292-F4BC4F35-721A-4AF7-A60B-C82AA563AF11Q37502385-F7D5EA7D-E239-487B-B63C-06FDACA44B7BQ38112352-37A348E4-ABFD-4FEC-ADA2-46F8D43D4E23Q38166829-6E867CF8-2D87-47F9-A463-32D4ECADE5C5Q40045035-492D4148-5FE5-4859-940F-72E9E98344E6Q41035406-06B7F172-1636-49BB-901B-CA95EAF284C7Q51038247-3D1E87E2-A73E-46D5-9395-4B28490CE6B3Q52838536-64A5449E-6468-4B3C-BC60-79F0BA43C548Q55380934-AEB1618A-C679-4126-961E-2ECAFA683BF6
P2860
Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetic engineering of trimers ...... t v 1, for allergy vaccination
@ast
Genetic engineering of trimers ...... t v 1, for allergy vaccination
@en
type
label
Genetic engineering of trimers ...... t v 1, for allergy vaccination
@ast
Genetic engineering of trimers ...... t v 1, for allergy vaccination
@en
prefLabel
Genetic engineering of trimers ...... t v 1, for allergy vaccination
@ast
Genetic engineering of trimers ...... t v 1, for allergy vaccination
@en
P2093
P2860
P1433
P1476
Genetic engineering of trimers ...... t v 1, for allergy vaccination
@en
P2093
Christian Baumgartner
Monika Fohr
Raffaela Campana
Rudolf Valenta
P2860
P304
P356
10.1016/J.VACCINE.2010.12.080
P407
P577
2011-01-05T00:00:00Z